Savvy Updates 5/30/22: Dexcom-Insulet Purchase Discussion, Medtronic’s Continuing Supply Chain Woes, Levicure Ltd Aims for Oral Treatment for T1D
How a Dexcom-Insulet combination would shake up the diabetes treatment industry was published by Ricky Zipp for MedTechDive.com, 25 May 2022. After last year’s barrage of deal-making in the medical device industry, there have been few acquisitions in...
Open Letter to the US FDA from The Savvy Diabetic re FDA, Interoperability Mandate and End-User On-Device, Continuous Access to OUR OWN CGM DATA
OPEN LETTER to: • Robert M. Califf, M.D., Commissioner of Food & Drugs, USFDA • Jeffrey E. Shuren, M.D., J.D. Director, Ctr for Devices & Radiological Health, US FDA • Kellie Kelm, Ph.D, Director, Office of Health Technology 7, US FDA • Yiduo Wu, Ph.D., Branch...
Savvy NEWS FLASH, 5/24/22: Dexcom Is in Talks to Acquire Device Firm Insulet
WOW, BIG NEWS!!! Dexcom Is in Talks to Acquire Device Firm Insulet was reported by Ed Hammond and Michelle F. Davis for Yahoo.com/Finance, 23 May 2022. Dexcom Inc. is in talks to acquire medical-device company Insulet Corp. in a deal that would create a giant in...
Savvy Updates 5/23/22: Evotec/Sernova Beta Cell Replacement Therapy for Cure to Diabetes, How Kidneys Actually Work, Neuropathy & Diabetes Fatigue
Evotec, Sernova Striving for Functional Diabetes Cure was published by Alex Keown for BioSpace.com, 17 May 2022. Two life sciences powerhouses are coming together to develop an off-the-shelf beta cell replacement therapy for insulin-dependent diabetes patients,...
Savvy Updates, 5/16/22: Dexcom G7 European Launch, Lilly Introduces Mounjaro, RECALL Skittles/Starburst/LifeSavers, Tattoo-like Sensors, A History of Insulin Pumps
Dexcom Chief Tech Officer Leach discusses G7’s European launch and FDA review, expanding Dexcom One as written by Ricky Zipp for MedTechDrive.com, 10 May 2022. Dexcom’s newest continuous glucose monitoring system, called G7, was released last quarter...
More Diabetes Blogs